<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Res Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Res Med Sci</journal-id><journal-id journal-id-type="publisher-id">JRMS</journal-id><journal-title-group><journal-title>Journal of Research in Medical Sciences : The Official Journal of Isfahan University of Medical Sciences</journal-title></journal-title-group><issn pub-type="ppub">1735-1995</issn><issn pub-type="epub">1735-7136</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26941818</article-id><article-id pub-id-type="pmc">4755101</article-id><article-id pub-id-type="publisher-id">JRMS-20-1121</article-id><article-id pub-id-type="doi">10.4103/1735-1995.172848</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letter to Editor</subject></subj-group></article-categories><title-group><article-title>Questions concerning &#x0201c;Chlorhexidine, octenidine, or povidone-iodine for catheter-related infections: A randomized controlled trial&#x0201d;</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Braun</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Siebert</surname><given-names>J&#x000f6;rg</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib></contrib-group><aff id="aff1">Department of Marketing Hygiene International, Sch&#x000fc;lke &#x00026; Mayr GmbH, Norderstedt, Germany</aff><aff id="aff2"><label>1</label>Department of Medical Affairs, Sch&#x000fc;lke &#x00026; Mayr GmbH, Norderstedt, Germany</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Michael Braun, Sch&#x000fc;lke &#x00026; Mayr GmbH, Robert-Koch-Street 2, Norderstedt - 22851, Germany. E-mail: <email xlink:href="michael.braun@schuelke.com">michael.braun@schuelke.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>11</month><year>2015</year></pub-date><volume>20</volume><issue>11</issue><fpage>1121</fpage><lpage>1122</lpage><permissions><copyright-statement>Copyright: &#x000a9; Journal of Research in Medical Sciences</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions></article-meta></front><body><p>Sir,</p><p>We read with interest the article by Bilir <italic>et al</italic>.[<xref rid="ref1" ref-type="bibr">1</xref>] as well as its associated conference abstract[<xref rid="ref2" ref-type="bibr">2</xref>] reporting a clinical trial of chlorhexidine, octenidine, and povidone-iodine for skin antisepsis with the purpose of preventing vascular catheter-related infections. The authors report that chlorhexidine is significantly better than the other two antiseptics in preventing catheter-related sepsis and catheter-related colonization. However, in our opinion, the study has several potential limitations that remain unaddressed. Therefore, we would like to ask the authors for clarification.</p><p>First, the product specifications are unclear. It has not been stated whether the investigated products are alcohol- or water-based antiseptics. It is well-known that alcohol-containing products are superior to water-based products, especially concerning the immediate microbicidal effect that is important at the point of vascular catheter insertion. To really compare the efficacy of the different active ingredients &#x02014; chlorhexidine, povidone-iodine, and octenidine dihydrochloride &#x02014; it should be ensured that all of them are applied in the same vehicle. Comparing water-based with alcohol-based products results in a serious bias favoring the latter.[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref>] Furthermore, for octenidine dihydrochloride, there is no information provided concerning the applied concentration. Without this, it is impossible to compare the different active ingredients. Second, the clinical criteria used to diagnose catheter-related colonization and catheter-related sepsis, remain unclear. The diagnosis of catheter colonization requires quantitative culture of the catheter tip.[<xref rid="ref5" ref-type="bibr">5</xref>] Cultures of the skin surrounding the catheter insertion site, as specified in the authors&#x02019; &#x0201c;Methods section&#x0201d;, are not adequate to diagnose catheter colonization.[<xref rid="ref5" ref-type="bibr">5</xref>] Without clearly prespecified criteria, as part of a study's &#x0201c;Methods section&#x0201d;, it remains unclear as to the kind of infections the patients exactly had, and whether they were relevant in the context of skin antisepsis.</p><p>Third, questions concerning the statistical analyses of study outcomes remain. The overall number of patients in the study is rather small, with a total of 57 patients (<italic>n</italic> = 19 per treatment arm). Additionally, although it is reported that a total of 109 catheters were studied, no information is provided concerning the distribution of multiple catheters and arterial or central venous catheters in the different treatment arms. Furthermore, the numbers of outcome events have not been specified. Only percentages of catheter-related sepsis and catheter-related colonization for each group are provided, but it remains unclear, whether these percentages apply to the number of patients in each group or to the number of catheters. Assuming that the outcome events were counted per group (e.g., 2 events per 19 patients), we have recalculated the statistics of this trial, using Fisher's exact test, and we did not find a statistically significant difference between the chlorhexidine and the octenidine groups, neither for catheter colonization nor for catheter-related sepsis.</p><p>It has been demonstrated in several clinical settings that octenidine dihydrochloride is an effective antiseptic that can be used for the prevention of catheter-related infections,[<xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref8" ref-type="bibr">8</xref>] and that it is at least equal to chlorhexidine concerning its antimicrobial properties.[<xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref10" ref-type="bibr">10</xref>] Therefore, we request the authors to address our remarks, while taking relevant literature into account.</p><sec disp-level="2" id="sec2-1"><title>Financial support and sponsorship</title><p>Nil.</p></sec><sec disp-level="2" id="sec2-2"><title>Conflicts of interest</title><p>Michael Braun and J&#x000f6;rg Siebert are employees of Sch&#x000fc;lke &#x00026; Mayr GmbH, Germany.</p></sec></body><back><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilir</surname><given-names>A</given-names></name><name><surname>Yelken</surname><given-names>B</given-names></name><name><surname>Erkan</surname><given-names>A</given-names></name></person-group><article-title>Cholorhexidine, octenidine or povidone iodine for catheter related infections: A randomized controlled trial</article-title><source>J Res Med Sci</source><year>2013</year><volume>18</volume><fpage>510</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">24250702</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilir</surname><given-names>A</given-names></name><name><surname>Yelken</surname><given-names>B</given-names></name><name><surname>Erkan</surname><given-names>A</given-names></name></person-group><article-title>Cholorhexidine, octenidine or povidone iodine for catheter-related infections: A randomised controlled trial</article-title><source>Crit Care</source><year>2009</year><volume>13</volume><issue>Suppl 1</issue><fpage>P194</fpage></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maiwald</surname><given-names>M</given-names></name><name><surname>Chan</surname><given-names>ES</given-names></name></person-group><article-title>The forgotten role of alcohol: A systematic review and meta-analysis of the clinical efficacy and perceived role of chlorhexidine in skin antisepsis</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>e44277</fpage><pub-id pub-id-type="pmid">22984485</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maiwald</surname><given-names>M</given-names></name><name><surname>Chan</surname><given-names>ES</given-names></name></person-group><article-title>Pitfalls in evidence assessment: The case of chlorhexidine and alcohol in skin antisepsis</article-title><source>J Antimicrob Chemother</source><year>2014</year><volume>69</volume><fpage>2017</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">24777898</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mermel</surname><given-names>LA</given-names></name><name><surname>Allon</surname><given-names>M</given-names></name><name><surname>Bouza</surname><given-names>E</given-names></name><name><surname>Craven</surname><given-names>DE</given-names></name><name><surname>Flynn</surname><given-names>P</given-names></name><name><surname>O&#x02019;Grady</surname><given-names>NP</given-names></name><etal/></person-group><article-title>Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America</article-title><source>Clin Infect Dis</source><year>2009</year><volume>49</volume><fpage>1</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">19489710</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dettenkofer</surname><given-names>M</given-names></name><name><surname>Jonas</surname><given-names>D</given-names></name><name><surname>Wiechmann</surname><given-names>C</given-names></name><name><surname>Rossner</surname><given-names>R</given-names></name><name><surname>Frank</surname><given-names>U</given-names></name><name><surname>Zentner</surname><given-names>J</given-names></name><etal/></person-group><article-title>Effect of skin disinfection with octenidine dihydrochloride on insertion site colonization of intravascular catheters</article-title><source>Infection</source><year>2002</year><volume>30</volume><fpage>282</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">12382087</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tietz</surname><given-names>A</given-names></name><name><surname>Frei</surname><given-names>R</given-names></name><name><surname>Dangel</surname><given-names>M</given-names></name><name><surname>Bolliger</surname><given-names>D</given-names></name><name><surname>Passweg</surname><given-names>JR</given-names></name><name><surname>Gratwohl</surname><given-names>A</given-names></name><etal/></person-group><article-title>Octenidine hydrochloride for the care of central venous catheter insertion sites in severely immunocompromised patients</article-title><source>Infect Control Hosp Epidemiol</source><year>2005</year><volume>26</volume><fpage>703</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16156327</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dettenkofer</surname><given-names>M</given-names></name><name><surname>Wilson</surname><given-names>C</given-names></name><name><surname>Gratwohl</surname><given-names>A</given-names></name><name><surname>Schmoor</surname><given-names>C</given-names></name><name><surname>Bertz</surname><given-names>H</given-names></name><name><surname>Frei</surname><given-names>R</given-names></name><etal/></person-group><article-title>Skin disinfection with octenidine dihydrochloride for central venous catheter site care: A double-blind, randomized, controlled trial</article-title><source>Clin Microbiol Infect</source><year>2010</year><volume>16</volume><fpage>600</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">19686276</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koburger</surname><given-names>T</given-names></name><name><surname>H&#x000fc;bner</surname><given-names>NO</given-names></name><name><surname>Braun</surname><given-names>M</given-names></name><name><surname>Siebert</surname><given-names>J</given-names></name><name><surname>Kramer</surname><given-names>A</given-names></name></person-group><article-title>Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate</article-title><source>J Antimicrob Chemother</source><year>2010</year><volume>65</volume><fpage>1712</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">20551215</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000fc;ller</surname><given-names>G</given-names></name><name><surname>Langer</surname><given-names>J</given-names></name><name><surname>Siebert</surname><given-names>J</given-names></name><name><surname>Kramer</surname><given-names>A</given-names></name></person-group><article-title>Residual antimicrobial effect of chlorhexidine digluconate and octenidine dihydrochloride on reconstructed human epidermis</article-title><source>Skin Pharmacol Physiol</source><year>2014</year><volume>27</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">23887383</pub-id></element-citation></ref></ref-list></back></article>